Analyst Price Targets — PEN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 6, 2026 12:46 pm | Vijay Kumar | Evercore ISI | $320.00 | $317.90 | TheFly | Penumbra price target lowered to $320 from $335 at Evercore ISI |
| May 7, 2026 12:06 pm | Vijay Kumar | Evercore ISI | $335.00 | $325.24 | TheFly | Penumbra price target lowered to $335 from $345 at Evercore ISI |
| February 26, 2026 3:48 pm | Priya Sachdeva | UBS | $374.00 | $340.24 | StreetInsider | UBS Reiterates Neutral Rating on Penumbra (PEN) Following Q4 Results |
| February 25, 2026 7:48 pm | — | Evercore ISI | $360.00 | $338.70 | TheFly | Penumbra price target raised to $360 from $340 at Evercore ISI |
| January 20, 2026 11:34 am | — | RBC Capital | $374.00 | $350.78 | TheFly | Penumbra downgraded to Sector Perform from Outperform at RBC Capital |
| January 20, 2026 10:06 am | — | Canaccord Genuity | $374.00 | $350.78 | TheFly | Penumbra downgraded to Hold from Buy at Canaccord |
| January 16, 2026 1:55 pm | — | Jefferies | $374.00 | $350.98 | TheFly | Penumbra downgraded to Hold from Buy at Jefferies |
| January 16, 2026 7:55 am | David Rescott | Robert W. Baird | $374.00 | $350.49 | StreetInsider | Baird Downgrades Penumbra (PEN) to Neutral |
| January 16, 2026 7:12 am | Mike Kratky | Leerink Partners | $374.00 | $350.49 | StreetInsider | Leerink Partners Downgrades Penumbra (PEN) to Market Perform |
| January 16, 2026 5:46 am | Richard Newitter | Truist Financial | $374.00 | $350.49 | StreetInsider | Truist Securities Downgrades Penumbra (PEN) to Hold |
Latest News for PEN
Connor Clark and Lunn Investment Management Ltd. purchased a new position in shares of Penumbra, Inc. (NYSE: PEN) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 5,111 shares of the company's stock, valued at approximately $1,614,000. A number of other institutional
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stocks?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now?
ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026.
Bank of Nova Scotia boosted its stake in Penumbra, Inc. (NYSE: PEN) by 14,837.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 211,820 shares of the company's stock after purchasing an additional 210,402 shares during the quarter. Bank
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PEN.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.